Pharmacologic Treatment for Temporomandibular and Temporomandibular Joint Disorders
Oral and Maxillofacial Surgery Clinics of North America · 2022-02 · 34 (1) · 49-59
DOI: 10.1016/j.coms.2021.08.001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oral and Maxillofacial Surgery Clinics of North America, 2022-02. Verfasst von Amanda Andre und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Brooklyn Hospital Center, 121 Dekalb Avenue, Brooklyn, NY 11201, USA. Electronic address: aafernandez@tbh.org. Hauptthemen laut MEDLINE: Temporomandibular Joint Disorders. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Temporomandibular joint disorder is defined by pain and/or loss of function of the temporomandibular joint and its associated muscles and structures. Treatments include noninvasive pharmacologic therapies, minimally invasive muscular and articular injections, and surgery. Conservative therapies include nonsteroidal anti-inflammatory drugs, muscle relaxants, benzodiazepines, antidepressants, and anticonvulsants. Minimally invasive injections include botulinum toxin, corticosteroids, platelet-rich plasma, hyaluronic acid, and prolotherapy with hypertonic glucose. With many pharmacologic treatment options and modalities available to the oral and maxillofacial surgeon, mild to moderate temporomandibular joint disorder can be managed safely and effectively to improve symptoms of pain and function of the temporomandibular joint.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Brooklyn Hospital Center, 121 Dekalb Avenue, Brooklyn, NY 11201, USA. Electronic address: aafernandez@tbh.org.
- The Brooklyn Hospital Center, 121 Dekalb Avenue, Brooklyn, NY 11201, USA.
Zitieren
APA
Andre, A., Kang, J., & Dym, H. (2022). Pharmacologic Treatment for Temporomandibular and Temporomandibular Joint Disorders. Oral and Maxillofacial Surgery Clinics of North America, 34(1), 49-59. https://doi.org/10.1016/j.coms.2021.08.001
Vancouver
Andre A, Kang J, Dym H. Pharmacologic Treatment for Temporomandibular and Temporomandibular Joint Disorders. Oral and Maxillofacial Surgery Clinics of North America. 2022;34(1):49-59. doi:10.1016/j.coms.2021.08.001
BibTeX
@article{Andre2022,
author = {Andre, Amanda and Kang, Joseph and Dym, Harry},
title = {Pharmacologic Treatment for Temporomandibular and Temporomandibular Joint Disorders},
journal = {Oral and Maxillofacial Surgery Clinics of North America},
year = {2022},
volume = {34},
number = {1},
pages = {49--59},
doi = {10.1016/j.coms.2021.08.001}
}
EUVIMED